These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
34. Increased serum thyroglobulin concentrations and impaired thyrotropin response to thyrotropin-releasing hormone in euthyroid subjects with endemic goiter in Sicily: their relation to goiter size and nodularity. Vermiglio F; Benvenga S; Melluso R; Catalfamo S; Princi P; Battiato S; Consolo F; Trimarchi F J Endocrinol Invest; 1986 Oct; 9(5):389-96. PubMed ID: 3098822 [TBL] [Abstract][Full Text] [Related]
35. Octreotide and bromocriptine suppress thyroid hormone levels and thyroid nodule in an acromegalic patient with nontoxic autonomous goiter. Sakane N; Yoshida T; Shimatsu A; Umekawa T; Kondo M Endocr J; 1997 Apr; 44(2):305-10. PubMed ID: 9228467 [TBL] [Abstract][Full Text] [Related]
36. Treatment of acromegaly with octreotide-LAR: extensive experience in a Brazilian institution. Jallad RS; Musolino NR; Salgado LR; Bronstein MD Clin Endocrinol (Oxf); 2005 Aug; 63(2):168-75. PubMed ID: 16060910 [TBL] [Abstract][Full Text] [Related]
37. [Correlation between serum thyroglobulin and thyroid stimulating hormone in populations with non-toxic goiter]. Hu FN; Jin Y; Teng WP; Yang F; Teng XC; Gao TS; Wang WB; Shi XG; Tao CM Zhonghua Yi Xue Za Zhi; 2003 Jun; 83(11):936-9. PubMed ID: 12899791 [TBL] [Abstract][Full Text] [Related]
38. Serum thyrotropin concentration as a novel predictor of malignancy in thyroid nodules investigated by fine-needle aspiration. Boelaert K; Horacek J; Holder RL; Watkinson JC; Sheppard MC; Franklyn JA J Clin Endocrinol Metab; 2006 Nov; 91(11):4295-301. PubMed ID: 16868053 [TBL] [Abstract][Full Text] [Related]
39. Cytopathological findings from fine-needle aspiration biopsy are accurate predictors of thyroid pathology in patients with functioning thyroid nodules. Zelmanovitz F; Gross JL J Endocrinol Invest; 1998 Feb; 21(2):98-101. PubMed ID: 9585383 [TBL] [Abstract][Full Text] [Related]
40. Evaluation of thyroid disease and thyroid malignancy in acromegalic patients. Cankurtaran Y; Örük GG; Tozduman B Minerva Endocrinol (Torino); 2023 Jun; 48(2):130-139. PubMed ID: 33988006 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]